Test of an interventional X-ray guidance device approved by the U.S. Food and Drug Administration in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy (IAT) for liver cancer, say Johns Hopkins researchers. In a report prepared for presentation Dec. 3 at the 100th annual meeting of the Radiological Society of North America in Chicago), the researchers described the results of a clinical trial of the imaging system ...
Read MoreYou have just read an article categorized health
titled New Imaging System Alternative to Intra-arterial Therapy (IAT) : a Boon to Liver Cancer Patients.
Written by:
editor - Thursday, November 27, 2014
There are currently no comments for "New Imaging System Alternative to Intra-arterial Therapy (IAT) : a Boon to Liver Cancer Patients"
Post a Comment